Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
7 clinical trials · Condition
◉ Watch Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma (NCT06561425) | Lakefront Biotherapeutics NV | 2022-03-09 |
| To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL) (NCT06698484) | National University of Malaysia | 2021-06-03 |
| Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT02625480) | Kite, A Gilead Company | 2016-02-01 |
Track Relapsed/Refractory B-cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.